
Get involved in research
If you or someone you know is interested in taking part in the Relief study, you can contact patientexperience@evrima.com.au to register your interest and receive further details about the study.
Not everyone who is interested in taking part in the study will be eligible to participate. This is because the sponsor company (Cerecin) has established inclusion criteria to ensure the safety of all clinical research participants, consistent with the regulatory requirements in Australia. Interested participants will be asked a series of pre-screening questions, including details about their medical history as well as current and previous migraine medication.
You should answer these questions honestly, so the research team can make an informed decision on whether it is in your best interest to take part.
Study sites
The Relief study is enrolling participants across several study sites in Australia.
Paratus Clinical Research Canberra
Paratus Clinical Research Brisbane
Alfred Health (Melbourne)
Gold Coast University Hospital (Southport)
Paratus Clinical Research Central Coast (Kanwal)
Paratus Clinical Research Western Sydney (Blacktown)
Centre for Neuroscience Innovation (Calvary Adelaide Hospital)
Holdsworth House (Sydney)
Emeritus Research (Camberwell)
Austin Health (Melbourne)
Affinity Clinical Research (Western Australia)